Literature DB >> 12539072

Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin.

Debra L Palazzi1, Kenneth L McClain, Sheldon L Kaplan.   

Abstract

To study the evolution of hemophagocytic syndrome (HPS) in children, we performed a retrospective review of 19 patients (median age, 17.4 months) in whom an infectious diseases consultation was requested at Texas Children's Hospital during the period of September 1991 through September 2001. Clinical findings consistent with HPS most frequently presented during days 6-14 of illness, concomitant with laboratory abnormalities. Fever was present for a median of 19 days before the diagnosis of HPS. Elevated serum lactate dehydrogenase and ferritin levels were noted in all patients. An infectious agent was identified in 42% of patients; 16% were found to have immunologic or vasculitic disease. HPS is a rare but often fatal disease that can initially present as fever of unknown origin with varying clinical findings, and it can be recognized by physicians who are familiar with the evolution of HPS. It is likely that many of these cases remain undiagnosed because of the HPS's rapidly fatal course.

Entities:  

Mesh:

Year:  2003        PMID: 12539072     DOI: 10.1086/345903

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  EBV-HLH children with reductions in CD4+ T cells and excessive activation of CD8+ T cells.

Authors:  Cheng Yang; Xiujuan Zhu; Ting Zhang; Qing Ye
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

2.  Familial haemophagocytic lymphohistiocytosis: two case reports.

Authors:  Marta Ferreira; Joana Martins; Catarina Silvestre; Clara Abadesso; Ester Matias; Helena Loureiro; António Figueiredo; Alexandra Dias; Helena Almeida
Journal:  BMJ Case Rep       Date:  2010-05-04

3.  Hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection in an immunocompetent infant: a diagnostic and therapeutic challenge!

Authors:  Sujata Kanhere; Manish Bhagat; Purvi Kadakia; Anuradha Joshi; Varsha Phadke; Kushagra Chaudhari
Journal:  Indian J Hematol Blood Transfus       Date:  2014-03-20       Impact factor: 0.900

Review 4.  How I treat hemophagocytic lymphohistiocytosis.

Authors:  Michael B Jordan; Carl E Allen; Sheila Weitzman; Alexandra H Filipovich; Kenneth L McClain
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

5.  Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality.

Authors:  Tiffany F Lin; Laura L Ferlic-Stark; Carl E Allen; Claudia A Kozinetz; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2011-01       Impact factor: 3.167

6.  Adult hemophagocytic lymphohistiocytosis with severe pulmonary hypertension and a novel perforin gene mutation.

Authors:  Lauren M Gerard; Katharine Xing; Ines Sherifi; John Granton; David Barth; Mohamed Abdelhaleem; Catherine Bergeron; Sheila Weitzman; Christine Cserti-Gazdewich
Journal:  Int J Hematol       Date:  2012-02-23       Impact factor: 2.490

7.  Prolonged fever and pancytopenia in a case of severe dengue may be secondary hemophagocytic lymphohistiocytosis.

Authors:  Vijoy Kumar Jha; Harshit Khurana; A Balakrishnan
Journal:  Med J Armed Forces India       Date:  2020-08-05

8.  Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis.

Authors:  Zaher K Otrock; Brenda J Grossman; Charles S Eby
Journal:  Int J Hematol       Date:  2018-07-24       Impact factor: 2.490

9.  Childhood tuberculosis presenting with haemophagocytic syndrome.

Authors:  Tarun Verma; Sameer Aggarwal
Journal:  Indian J Hematol Blood Transfus       Date:  2011-10-08       Impact factor: 0.900

Review 10.  Enterovirus-associated hemophagocytic syndrome in children with malignancy: report of three cases and review of the literature.

Authors:  Katerina Katsibardi; Maria A Moschovi; Maria Theodoridou; Nicholas Spanakis; Panagiotis Kalabalikis; Athanassios Tsakris; Fotini Tzortzatou-Stathopoulou
Journal:  Eur J Pediatr       Date:  2007-02-22       Impact factor: 3.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.